LCMD plans initial commercialization of Keyhole Cup Laparoscopic Access Device in Q3 2013

Life Care Medical Devices Ltd (OTCBB: LCMD) today announced the issuance in August 2012 of CE mark for its Keyhole Cup Laparoscopic Access Device. Keyhole Cup addresses a critical need in the laparoscopic surgery market (one of the largest medical procedure markets) and was developed to advance the standard of care for laparoscopic access.

The initial surgical access to the abdominal region of the body has been, to date, a fully manual procedure involving either a veress needle or a cut down procedure known as the Hassan technique. These techniques, while effective, are labor and time intensive and contain an element of risk in that the instruments used in these are introduced into the abdominal cavity without an element of visualization. This lack of visualization carries with it inherent risk of injury to organs lying beneath the abdominal wall such as the intestines.  Through the application of negative pressure to the dome shaped Keyhole Cup device, the abdominal wall is separated from the underlying organs allowing for a safe and rapid entry of a veress needle for the introduction of inert gas and resulting insufflation of the abdomen followed by surgical intervention.

"While surgical equipment advances and technique improvement have been an integral part of the development of the laparoscopic surgery market, the initial first step of access to the abdominal cavity has remained static," said Glenn Foley , Chief Executive Officer of Life Care Medical Devices Ltd. "Our Keyhole Cup Laparoscopic Surgery Access Device gives the surgeon a method for rapid, consistent, and safe access to the abdominal region." 

"With our recent capital raise," continued Mr. Foley, "LCMD is currently in the process of distribution partner selection and plans initial commercialization in Q3 2013."